FKRP and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Despite significant advances in understanding the causes and clinical manifestation of dystroglycanopathies, almost no progress has been made for the treatment of the diseases including those caused by FKRP mutations.